13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0002003147
Total reported value
$586.5M
$586.5M
14 檔
32.2%
In Q4 2025, Davern Capital Partners, LP's U.S. equity holdings reached a combined market value of $586.5M, distributed across 14 disclosed stock positions.
During Q4 2025, Davern Capital Partners, LP's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | PFE | Pfizer Inc | Stock-Healthcare | 16.44% | -12.28% | EXIT | |
| 2 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 13.08% | +0.35% | — | |
| 3 | BNTX | Biontech Se-adr | Stock-Other | 11.43% | +4.53% | — | |
| 4 | RPRX | Royalty Pharma plc | Stock-Healthcare | 10.50% | +4.21% | — | |
| 5 | ARGX | Argenx Se - Adr | Stock-Healthcare | 9.70% | -7.02% | EXIT | |
| 6 | LEGN | Legend Biotech Corp-adr | Stock-Other | 7.43% | -0.65% | — | |
| 7 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 7.21% | +5.02% | — | |
| 8 | IONS | Ionis Pharmaceuticals Inc | Stock-Healthcare | 6.10% | +2.83% | — | |
| 9 | NTRA | Natera Inc | Stock-Healthcare | 5.83% | -2.39% | — | |
| 10 | LLY | Eli Lilly & Co | Stock-Healthcare | 2.89% | -6.88% | EXIT | |
| 11 | VRDN | Viridian Therapeutics Inc | Stock-Other | 2.63% | -1.62% | EXIT | |
| 12 | MLYS | Mineralys Therapeutics Inc | Stock-Other | 2.47% | +0.63% | — | |
| 13 | CGON | Cg Oncology Inc | Stock-Other | 2.17% | — | — | |
| 14 | ABVX | Abivax Sa-adr | Stock-Other | 2.11% | -2.39% | EXIT |
According to official SEC Form 13F filings, Davern Capital Partners, LP reported a total U.S. public equity portfolio value of $586.5M across 14 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including PFE, REGN, BNTX) accounted for 32.2% of total reported equity market value during Q4 2025.
During Q4 2025, Davern Capital Partners, LP's top holdings by market value included PFE (16.4%)、REGN (13.1%)、BNTX (11.4%). The largest single position, PFE, represented 16.4% of total portfolio value.
In Q4 2025, Davern Capital Partners, LP made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.